Stentex is a joint venture between Medtronic, one of the world's largest medical technology companies, and the Renova Group, Russia’s leading private business group.
The company will produce high-quality coronary stents and balloon catheters with proven clinical efficacy, using the technology of world leader Medtronic. The company will become the largest Russian enterprise in the medical industry, creating about 700 jobs in the high technology sector of the medical industry.
Stentex mission is to help save lives and improve the wellbeing of patients with the most technically advanced and clinically proven therapies produced in Russia. Being part of an ambitious strategy to reduce ACS in Russia, the Stentex aims to make its suite of products available to every patient across Russia who needs them.
The company also develops bioresorbable vascular stents of the next generation in its R&D subsidiary Biosten, http://www.biosten.ru